Synthesis and pharmacological screening of derivatives of isoxazolo[4, 3-d]pyridimidine.I. 1994

K Poreba, and E Wagner, and I Jakowicz, and D Balika
Department of Technology of Drugs, Medical Academy, Wroclaw, Poland.

The synthesis of new derivatives of isoxazole and new derivatives of isoxazolo[4,3-d]pyridine is described. The anticonvulsant and anxiolytic activity of some isoxazolo[4,3-d]pyrimidine derivatives was tested in a preliminary screening.

UI MeSH Term Description Entries
D007555 Isoxazoles Azoles with an OXYGEN and a NITROGEN next to each other at the 1,2 positions, in contrast to OXAZOLES that have nitrogens at the 1,3 positions. Isoxazole
D008297 Male Males
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000927 Anticonvulsants Drugs used to prevent SEIZURES or reduce their severity. Anticonvulsant,Anticonvulsant Drug,Anticonvulsive Agent,Anticonvulsive Drug,Antiepileptic,Antiepileptic Agent,Antiepileptic Agents,Antiepileptic Drug,Anticonvulsant Drugs,Anticonvulsive Agents,Anticonvulsive Drugs,Antiepileptic Drugs,Antiepileptics,Agent, Anticonvulsive,Agent, Antiepileptic,Agents, Anticonvulsive,Agents, Antiepileptic,Drug, Anticonvulsant,Drug, Anticonvulsive,Drug, Antiepileptic,Drugs, Anticonvulsant,Drugs, Anticonvulsive,Drugs, Antiepileptic
D014151 Anti-Anxiety Agents Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. Anti-Anxiety Agent,Anti-Anxiety Drug,Anxiolytic,Anxiolytic Agent,Anxiolytic Agents,Tranquilizing Agents, Minor,Anti-Anxiety Drugs,Anti-Anxiety Effect,Anti-Anxiety Effects,Antianxiety Effect,Antianxiety Effects,Anxiolytic Effect,Anxiolytic Effects,Anxiolytics,Tranquillizing Agents, Minor,Agent, Anti-Anxiety,Agent, Anxiolytic,Agents, Anti-Anxiety,Agents, Anxiolytic,Agents, Minor Tranquilizing,Agents, Minor Tranquillizing,Anti Anxiety Agent,Anti Anxiety Agents,Anti Anxiety Drug,Anti Anxiety Drugs,Anti Anxiety Effect,Anti Anxiety Effects,Drug, Anti-Anxiety,Drugs, Anti-Anxiety,Effect, Anti-Anxiety,Effect, Antianxiety,Effect, Anxiolytic,Effects, Anti-Anxiety,Effects, Antianxiety,Effects, Anxiolytic,Minor Tranquilizing Agents,Minor Tranquillizing Agents
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

K Poreba, and E Wagner, and I Jakowicz, and D Balika
November 2008, European journal of medicinal chemistry,
K Poreba, and E Wagner, and I Jakowicz, and D Balika
January 2004, Bioorganic & medicinal chemistry,
K Poreba, and E Wagner, and I Jakowicz, and D Balika
January 1988, Polish journal of pharmacology and pharmacy,
K Poreba, and E Wagner, and I Jakowicz, and D Balika
January 1984, Acta poloniae pharmaceutica,
K Poreba, and E Wagner, and I Jakowicz, and D Balika
February 2015, Bioorganic & medicinal chemistry letters,
K Poreba, and E Wagner, and I Jakowicz, and D Balika
September 2022, Chemistry & biodiversity,
K Poreba, and E Wagner, and I Jakowicz, and D Balika
January 1979, Acta poloniae pharmaceutica,
K Poreba, and E Wagner, and I Jakowicz, and D Balika
June 2010, European journal of medicinal chemistry,
K Poreba, and E Wagner, and I Jakowicz, and D Balika
January 1986, Polish journal of pharmacology and pharmacy,
K Poreba, and E Wagner, and I Jakowicz, and D Balika
December 1972, Bollettino chimico farmaceutico,
Copied contents to your clipboard!